Background Glycobiology is an underexplored research area in inflammatory bowel disease
(IBD), and glycans are relevant to many etiological mechanisms described in IBD …

Current data indicate a change in the epidemiology of inflammatory bowel diseases. The
disease has become more widespread and the rise in the incidence has been reported in all …

Background and Aims Causes of inflammatory bowel diseases are not well understood and
the most prominent forms, Crohn's disease (CD) and ulcerative colitis (UC), are sometimes …

Inflammatory bowel diseases (IBD) are an example of chronic diseases affecting 40% of the
population, which involved tissue damage and an inflammatory process not satisfactorily …

Background Globally, the incidence rates of inflammatory bowel disease (IBD) are
increasing; however, data from high‐incidence areas are conflicting. Previous studies in …

Ulcerative colitis (UC), which is a major form of inflammatory bowel disease (IBD), is a
chronic relapsing disorder of the gastrointestinal tract affecting millions of people worldwide …

The incidence of inflammatory bowel diseases (IBD)-Crohn's disease (CD) and ulcerative
colitis (UC)-has been increasing on a global scale, and progressively, more …

Colorectal cancer (CRC) has become the fourth leading cause of cancer‐related death in
the worldwide. It is urgent to find more effective therapeutic strategies for it. Reactive oxygen …

Objective A global increase of IBD has been reported, especially in countries that previously
had low incidence rates. Also, the knowledge of the human gut microbiome is steadily …

OBJECTIVES: In this population-based 7-year follow-up of incident patients with ulcerative
colitis (UC) or Crohn's disease (CD), we aimed to describe disease progression and surgery …